Literature DB >> 30514565

Ubiquitination and phosphorylation of the CARD11-BCL10-MALT1 signalosome in T cells.

Marie Lork1, Jens Staal1, Rudi Beyaert2.   

Abstract

Antigen receptor-induced signaling plays an important role in inflammation and immunity. Formation of a CARD11-BCL10-MALT1 (CBM) signaling complex is a key event in T- and B cell receptor-induced gene expression by regulating NF-κB activation and mRNA stability. Deregulated CARD11, BCL10 or MALT1 expression or CBM signaling have been associated with immunodeficiency, autoimmunity and cancer, indicating that CBM formation and function have to be tightly regulated. Over the past years great progress has been made in deciphering the molecular mechanisms of assembly and disassembly of the CBM complex. In this context, several posttranslational modifications play an indispensable role in regulating CBM function and downstream signal transduction. In this review we summarize how the different CBM components as well as their interplay are regulated by protein ubiquitination and phosphorylation in the context of T cell receptor signaling.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  BCL10; CARD11; Immunity; Inflammation; Lymphocytes; MALT1; NF-κB; Phosphorylation; T cells; Ubiquitin

Mesh:

Substances:

Year:  2018        PMID: 30514565     DOI: 10.1016/j.cellimm.2018.11.001

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  13 in total

1.  Special Issue: E3 ubiquitin ligases, the match makers and grim reapers of immune cells.

Authors:  Emily Moser; Paula M Oliver
Journal:  Cell Immunol       Date:  2019-05-10       Impact factor: 4.868

2.  Coordinated regulation of scaffold opening and enzymatic activity during CARD11 signaling.

Authors:  Zhaoquan Wang; Shelby M Hutcherson; Chao Yang; Rakhi P Jattani; Julia M Tritapoe; Yong-Kang Yang; Joel L Pomerantz
Journal:  J Biol Chem       Date:  2019-08-07       Impact factor: 5.157

3.  MALT1 positively relates to Th17 cells, inflammation/activity degree, and its decrement along with treatment reflects TNF inhibitor response in ankylosing spondylitis patients.

Authors:  Jie Yuan; Lei Xiang; Feng Wang; Lin Zhang; Gaozhan Liu; Xiuli Chang; Anbing Zhang; Ying Tao
Journal:  J Clin Lab Anal       Date:  2022-05-27       Impact factor: 3.124

Review 4.  Reconsidering phosphorylation in the control of inducible CARD11 scaffold activity during antigen receptor signaling.

Authors:  Joel L Pomerantz
Journal:  Adv Biol Regul       Date:  2020-12-18

Review 5.  NFκB and Kidney Injury.

Authors:  Ning Song; Friedrich Thaiss; Linlin Guo
Journal:  Front Immunol       Date:  2019-04-16       Impact factor: 7.561

6.  Light-Controlled Affinity Purification of Protein Complexes Exemplified by the Resting ZAP70 Interactome.

Authors:  Maximilian Hörner; Julian Eble; O Sascha Yousefi; Jennifer Schwarz; Bettina Warscheid; Wilfried Weber; Wolfgang W A Schamel
Journal:  Front Immunol       Date:  2019-02-26       Impact factor: 7.561

7.  MALT1 Proteolytic Activity Suppresses Autoimmunity in a T Cell Intrinsic Manner.

Authors:  Annelies Demeyer; Ioannis Skordos; Yasmine Driege; Marja Kreike; Tino Hochepied; Mathijs Baens; Jens Staal; Rudi Beyaert
Journal:  Front Immunol       Date:  2019-08-14       Impact factor: 7.561

Review 8.  USP2-Related Cellular Signaling and Consequent Pathophysiological Outcomes.

Authors:  Hiroshi Kitamura; Mayuko Hashimoto
Journal:  Int J Mol Sci       Date:  2021-01-26       Impact factor: 5.923

9.  Cellular CARD11 Inhibits the Fusogenic Activity of Newcastle Disease Virus via CBM Signalosome-Mediated Furin Reduction in Chicken Fibroblasts.

Authors:  Wenbin Wang; Qiaolin Wei; Qiqi Hao; Yajie Zhang; Yongshan Li; Youkun Bi; Zhongyuan Jin; Haijin Liu; Xuelan Liu; Zengqi Yang; Sa Xiao
Journal:  Front Microbiol       Date:  2021-02-02       Impact factor: 5.640

10.  Cellular and Mathematical Analyses of LUBAC Involvement in T Cell Receptor-Mediated NF-κB Activation Pathway.

Authors:  Daisuke Oikawa; Naoya Hatanaka; Takashi Suzuki; Fuminori Tokunaga
Journal:  Front Immunol       Date:  2020-11-23       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.